WNDW SolarWindow Technologies, Inc.
Industrial Organic Chemicals · OTC · SEC CIK 1071840 · Fiscal year ends 08/31
Financial factors as of 2026-05-31 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY1.4%
TTM EPS YoY-0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-61.9%
ROA-56.7%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets6.3%
Debt / equity0.00x
Current ratio15.80x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.95x
Accruals ratio-3.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-08-31 | FY20242024-08-31 | FY20232023-08-31 | FY20222022-08-31 | FY20212021-08-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | $0 | $0 | — | — |
| R&D expense | $621,885 | $593,988 | $764,827 | $901,976 | $1.66M |
| SG&A expense | $1.73M | $2.01M | $1.55M | $2.85M | $6.28M |
| Operating income | -$2.36M | -$2.61M | -$2.31M | -$3.75M | -$7.94M |
| Pretax income | -$2.26M | -$3.06M | -$2.36M | -$4.95M | -$7.91M |
| Income tax | — | $0 | $0 | — | — |
| Net income | -$2.26M | -$3.46M | -$2.40M | -$4.95M | -$7.91M |
| EBITDA | -$2.35M | -$2.59M | -$2.30M | -$3.72M | -$7.91M |
| EPS (basic) | -0.04 | -0.06 | -0.04 | -0.09 | -0.15 |
| EPS (diluted) | -0.04 | -0.06 | -0.04 | -0.09 | -0.15 |
| Weighted avg. shares (diluted) | 55.82M | 53.20M | 53.20M | 53.20M | 53.11M |
| Banking | |||||
| Net interest income | $144,353 | $242,371 | $246,491 | $45,099 | $36,770 |
| Balance sheet | |||||
| Cash & equivalents | $6.56M | $1.25M | $492,610 | $8.08M | $7.13M |
| Short-term investments | — | $3.00M | $5.50M | — | $5.00M |
| Current assets | $6.60M | $4.99M | $6.30M | $8.36M | $12.32M |
| PP&E, net | $43,089 | $13,458 | $1.32M | $1.33M | $1.39M |
| Total assets | $6.65M | $5.00M | $7.62M | $9.69M | $13.73M |
| Current liabilities | $194,175 | $321,512 | $287,226 | $118,376 | $170,152 |
| Total liabilities | $194,175 | $321,512 | $287,226 | $118,376 | $170,152 |
| Shareholders' equity | $6.45M | $4.68M | $7.33M | $9.57M | $13.56M |
| Shares outstanding | 65.78M | 53.20M | 53.20M | 53.20M | 53.20M |
| Cash flow statement | |||||
| Operating cash flow | -$1.50M | -$1.74M | -$2.08M | -$3.64M | -$2.66M |
| Capital expenditure | $37,687 | $1,949 | $0 | $356,966 | $76,338 |
| Free cash flow | -$1.54M | -$1.74M | -$2.08M | -$4.00M | -$2.74M |
| Investing cash flow | $2.96M | $2.50M | -$5.50M | $4.64M | -$5.07M |
| Financing cash flow | $3.85M | — | — | — | $724,872 |
| Depreciation & amortization | $8,056 | $11,118 | $14,709 | $30,024 | $27,794 |
| Stock-based compensation | $103,125 | $403,520 | $159,382 | $1.02M | $4.79M |
Free plan shows the latest 5 periods; Pro shows all 27 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.